Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$163.68
-2.8%
$178.11
$122.00
$208.30
$11.71B1.71.17 million shs243,705 shs
Chemed Corporation stock logo
CHE
Chemed
$421.15
-1.1%
$396.39
$365.20
$583.96
$5.58B0.54234,945 shs42,151 shs
Encompass Health Corporation stock logo
EHC
Encompass Health
$107.86
+0.7%
$103.05
$92.77
$127.99
$10.70B0.721.15 million shs140,205 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$323.33
+0.4%
$261.47
$202.79
$325.34
$22.86B1.17974,067 shs199,907 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
-3.19%-4.33%+0.91%-10.24%-2.22%
Chemed Corporation stock logo
CHE
Chemed
+0.07%+0.04%+9.50%-4.95%-26.31%
Encompass Health Corporation stock logo
EHC
Encompass Health
+1.93%+7.05%+1.40%+1.57%-8.78%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
+2.79%+8.41%+24.23%+29.43%+51.36%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$163.68
-2.8%
$178.11
$122.00
$208.30
$11.71B1.71.17 million shs243,705 shs
Chemed Corporation stock logo
CHE
Chemed
$421.15
-1.1%
$396.39
$365.20
$583.96
$5.58B0.54234,945 shs42,151 shs
Encompass Health Corporation stock logo
EHC
Encompass Health
$107.86
+0.7%
$103.05
$92.77
$127.99
$10.70B0.721.15 million shs140,205 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$323.33
+0.4%
$261.47
$202.79
$325.34
$22.86B1.17974,067 shs199,907 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
-3.19%-4.33%+0.91%-10.24%-2.22%
Chemed Corporation stock logo
CHE
Chemed
+0.07%+0.04%+9.50%-4.95%-26.31%
Encompass Health Corporation stock logo
EHC
Encompass Health
+1.93%+7.05%+1.40%+1.57%-8.78%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
+2.79%+8.41%+24.23%+29.43%+51.36%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.57
Moderate Buy$205.8525.76% Upside
Chemed Corporation stock logo
CHE
Chemed
2.33
Hold$501.5019.08% Upside
Encompass Health Corporation stock logo
EHC
Encompass Health
3.11
Buy$144.1733.66% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.75
Moderate Buy$322.89-0.14% Downside

Current Analyst Ratings Breakdown

Latest WST, CHE, EHC, and ALGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/5/2026
Encompass Health Corporation stock logo
EHC
Encompass Health
Lower Price TargetOverweight$153.00 ➝ $140.00
4/30/2026
Align Technology, Inc. stock logo
ALGN
Align Technology
Boost Price Target$200.00 ➝ $220.00
4/30/2026
Align Technology, Inc. stock logo
ALGN
Align Technology
Boost Price Target$225.00 ➝ $230.00
4/29/2026
Chemed Corporation stock logo
CHE
Chemed
UpgradeSell (D+)Hold (C-)
4/27/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
UpgradeHold (C-)Hold (C)
4/27/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Set Price Target$315.00
4/27/2026
Chemed Corporation stock logo
CHE
Chemed
Boost Price TargetSector Perform$422.00 ➝ $436.00
4/27/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Boost Price TargetEqual Weight$275.00 ➝ $310.00
4/27/2026
Chemed Corporation stock logo
CHE
Chemed
UpgradeStrong SellHold
4/24/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Reiterated RatingBuy
4/24/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Reiterated RatingOutperform
(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$4.03B2.91$11.17 per share14.65$57.94 per share2.82
Chemed Corporation stock logo
CHE
Chemed
$2.53B2.21$24.47 per share17.21$63.88 per share6.59
Encompass Health Corporation stock logo
EHC
Encompass Health
$5.94B1.80$9.13 per share11.81$33.35 per share3.23
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$3.07B7.43$10.07 per share32.10$42.33 per share7.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$410.35M$5.9627.4315.781.7910.50%15.82%10.17%N/A
Chemed Corporation stock logo
CHE
Chemed
$265.24M$18.3522.9016.531.5910.23%27.18%17.38%N/A
Encompass Health Corporation stock logo
EHC
Encompass Health
$566.20M$5.9918.0116.702.2910.04%18.28%8.27%N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$493.70M$7.4843.2634.252.6116.85%19.03%14.06%7/23/2026 (Estimated)

Latest WST, CHE, EHC, and ALGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2026Q1 2026
Encompass Health Corporation stock logo
EHC
Encompass Health
$1.51$1.60+$0.09$1.93$1.57 billion$1.59 billion
4/29/2026Q1 2026
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.26$2.58+$0.32$1.57$1.02 billion$1.04 billion
4/23/2026Q1 2026
Chemed Corporation stock logo
CHE
Chemed
$5.30$5.65+$0.35$4.84$659.22 million$657.51 million
4/23/2026Q1 2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.68$2.13+$0.45$1.92$779.68 million$844.90 million
2/25/2026Q4 2025
Chemed Corporation stock logo
CHE
Chemed
$7.02$6.42-$0.60$5.48$659.09 million$639.34 million
2/12/2026Q4 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.83$2.04+$0.21$1.82$795.70 million$805.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
Chemed Corporation stock logo
CHE
Chemed
$2.400.57%+10.76%13.08%16 Years
Encompass Health Corporation stock logo
EHC
Encompass Health
$0.760.70%-8.97%12.69%2 Years
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.880.27%+5.51%11.76%N/A

Latest WST, CHE, EHC, and ALGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2026
Encompass Health Corporation stock logo
EHC
Encompass Health
quarterly$0.190.71%7/1/20267/1/20267/15/2026
2/16/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.220.3%4/29/20264/29/20265/6/2026
2/19/2026
Encompass Health Corporation stock logo
EHC
Encompass Health
quarterly$0.190.78%4/1/20264/1/20264/15/2026
2/13/2026
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.600.5%2/23/20262/23/20263/13/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.39
1.28
Chemed Corporation stock logo
CHE
Chemed
0.11
0.85
0.83
Encompass Health Corporation stock logo
EHC
Encompass Health
0.76
1.17
1.08
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.07
2.71
2.04

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
Chemed Corporation stock logo
CHE
Chemed
95.85%
Encompass Health Corporation stock logo
EHC
Encompass Health
97.25%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.75%
Chemed Corporation stock logo
CHE
Chemed
3.33%
Encompass Health Corporation stock logo
EHC
Encompass Health
1.80%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
20,29071.62 million71.08 millionOptionable
Chemed Corporation stock logo
CHE
Chemed
15,81113.27 million12.83 millionOptionable
Encompass Health Corporation stock logo
EHC
Encompass Health
42,00099.20 million97.41 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,80070.65 million70.22 millionOptionable

Recent News About These Companies

Best Momentum Stocks to Buy for April 29th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Align Technology stock logo

Align Technology NASDAQ:ALGN

$163.68 -4.71 (-2.80%)
As of 11:21 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Chemed stock logo

Chemed NYSE:CHE

$421.15 -4.67 (-1.10%)
As of 11:21 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Encompass Health stock logo

Encompass Health NYSE:EHC

$107.86 +0.71 (+0.66%)
As of 11:21 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$323.33 +1.32 (+0.41%)
As of 11:21 AM Eastern
This is a fair market value price provided by Massive. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.